S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
The single greatest medical breakthrough of all time? (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
The single greatest medical breakthrough of all time? (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
The single greatest medical breakthrough of all time? (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
The single greatest medical breakthrough of all time? (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
NASDAQ:MRVI

Maravai LifeSciences - MRVI Earnings Date, Estimates & Call Transcripts

$14.40
-0.48 (-3.23%)
(As of 12/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$14.32
$14.95
50-Day Range
$13.47
$25.82
52-Week Range
$13.40
$44.24
Volume
1.51 million shs
Average Volume
1.82 million shs
Market Capitalization
$3.67 billion
P/E Ratio
8.04
Dividend Yield
N/A
Price Target
$24.33
Skip Charts & View Estimated and Actual Earnings Data

MRVI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MRVI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Maravai LifeSciences Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20223$0.42$0.44$0.43 
Q2 20223$0.43$0.45$0.44 
Q3 20223$0.34$0.46$0.41 
Q4 20223$0.33$0.36$0.34 
FY 202212$1.52$1.71$1.62 
Q1 20232$0.23$0.42$0.33 
Q2 20232$0.24$0.44$0.34 
Q3 20232$0.25$0.45$0.35 
Q4 20232$0.11$0.48$0.30 
FY 20238$0.83$1.79 $1.31

MRVI Earnings Date and Information

Maravai LifeSciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 22nd, 2023 based off prior year's report dates.

Maravai LifeSciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/22/2023
(Estimated)
        
8/4/2022Q2 2022$0.45$0.54+$0.09$0.55$234.91 million$242.73 million
5/5/2022Q1 2022$0.43$0.54+$0.11$0.58$232.29 million$244.30 million    
2/23/2022Q4 2021$0.38$0.45+$0.07$0.48$208.09 million$228.44 million    
11/10/20219/30/2021$0.35$0.44+$0.09$0.65$199.68 million$204.81 million    
8/10/20216/30/2021$0.32$0.44+$0.12$0.44$195.49 million$217.80 million    
5/10/20213/31/2021$0.19$0.26+$0.07$0.28$135.36 million$148.20 million  
3/1/202112/31/2020$0.11$0.13+$0.02$0.13$87.48 million$98.35 million  












Maravai LifeSciences Earnings - Frequently Asked Questions

When is Maravai LifeSciences's earnings date?

Maravai LifeSciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 22nd, 2023 based off last year's report dates. Learn more on MRVI's earnings history.

How much revenue does Maravai LifeSciences generate each year?

Maravai LifeSciences (NASDAQ:MRVI) has a recorded annual revenue of $799.24 million.

How much profit does Maravai LifeSciences generate each year?

Maravai LifeSciences (NASDAQ:MRVI) has a recorded net income of $182.04 million. MRVI has generated $1.79 earnings per share over the last four quarters.

What is Maravai LifeSciences's price-to-earnings ratio?

Maravai LifeSciences (NASDAQ:MRVI) has a trailing price-to-earnings ratio of 8.04 and a forward price-to-earnings ratio of 8.04.

What is Maravai LifeSciences's EPS forecast for next year?

Maravai LifeSciences's earnings are expected to decrease from $1.79 per share to $0.36 per share in the next year, which is a -79.89% change.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:MRVI) was last updated on 12/2/2022 by MarketBeat.com Staff